Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Friday 14th June, SOE 2019 – Strabismus

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 14th 2019

Dr Mohammad Jaafar introduces the session on ‘Strabismus’ at SOE 2019, featuring:

– Re-Operations in Monocular Superior Oblique Palsy, Mohamad Jaafar, United States (0:38)
– Surgical Overcorrection in Moderate Angle Hypertropias Due to Unilateral Fourth Nerve Palsy,
David Nash, United States (13:55)
– Iatrogenic Strabismus, Faruk Örge, United States (26:07)
– When There’s Hardware in the Way – Managing Strabismus After Tubes and Buckles, Stephen Christiansen, United States (40:40)
– Partial vs. Full Plus Correction of Accommodative Esotropia, Ben Ticho, United States (55:43)
– Short and Long Term Results of Tendon Plication for Paralytic Strabismus: A Case Series,
Patrick Droste, United States (1:06:32)

Filmed in partnership with the European Society of Ophthalmology (SOE) at the SOE 2019 meeting in Nice, France.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup